{"product_id":"vimpat-150-mg-con-28-tabletas-lacosamida","title":"Vimpat 150 mg with 28 tablets (Lacosamide)","description":"\u003ch2\u003eCategory\u003c\/h2\u003e\n\u003cp\u003eControlled-use medications\u003c\/p\u003e\n\n\u003ch2\u003eLine\u003c\/h2\u003e\n\u003cp\u003eAntiepileptics\u003c\/p\u003e\n\n\u003ch2\u003eBrand\u003c\/h2\u003e\n\u003cp\u003eVimpat\u003c\/p\u003e\n\n\u003ch2\u003eMolecule\u003c\/h2\u003e\n\u003cp\u003eLacosamide\u003c\/p\u003e\n\n\u003ch2\u003ePresentation\u003c\/h2\u003e\n\u003cp\u003e28 Tablets of 150 mg\u003c\/p\u003e\n\n\u003ch2\u003eLaboratory\u003c\/h2\u003e\n\u003cp\u003eUcb Pharma\u003c\/p\u003e\n\n\u003ch2\u003eIndications\u003c\/h2\u003e\n\u003cp\u003eVimpat (lacosamide) is indicated as adjunctive therapy in adult and pediatric patients aged 4 years and older with partial epilepsy who are not adequately controlled with other antiepileptic drugs. The efficacy of Vimpat has been demonstrated in clinical trials to reduce the frequency of epileptic seizures. Additionally, its use is recommended in patients with focal seizures that may generalize. It is essential that treatment be supervised by a neurologist or epileptologist, who will determine the appropriate dose and duration of treatment according to the patient's individual needs.\u003c\/p\u003e\n\n\u003ch2\u003eComposition\u003c\/h2\u003e\n\u003cp\u003eEach tablet contains 150 mg of lacosamide. Excipients include: microcrystalline cellulose, starch, magnesium stearate, among others.\u003c\/p\u003e\n\n\u003ch2\u003eContraindications\u003c\/h2\u003e\n\u003cp\u003eVimpat is contraindicated in patients with known hypersensitivity to lacosamide or any of the excipients in the formula. Its use is not recommended in patients with severe renal failure requiring dialysis, as well as in those with a history of heart block or severe arrhythmias.\u003c\/p\u003e\n\n\u003ch2\u003ePrecautions\u003c\/h2\u003e\n\u003cp\u003eCaution should be exercised in patients with a history of heart problems, as lacosamide may cause PR interval prolongation and alterations in cardiac conduction. Likewise, it is recommended to monitor the patient's condition in case of adverse effects during treatment. The medication should not be abruptly discontinued, as this may increase the risk of epileptic seizures.\u003c\/p\u003e\n\n\u003ch2\u003eStorage\u003c\/h2\u003e\n\u003cp\u003eStore at room temperature, between 15 and 30 °C. Keep in a dry place and protected from light. Keep out of reach of children.\u003c\/p\u003e\n\n\u003cp\u003ePrescription required.\u003c\/p\u003e\n\u003cp\u003eConsult your doctor.\u003c\/p\u003e","brand":"Ucb Pharma","offers":[{"title":"Default Title","offer_id":45849201606881,"sku":"7501088506758","price":2290.62,"currency_code":"MXN","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0722\/1500\/3361\/files\/planogram__1__07e278e5-213a-4738-9d8f-9463792a3161.jpg?v=1744696106","url":"https:\/\/wecarepharma.mx\/en\/products\/vimpat-150-mg-con-28-tabletas-lacosamida","provider":"WeCare Pharma","version":"1.0","type":"link"}